Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 983

1.

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.

Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, Stephenson H, Schatzberg AF.

Arch Gen Psychiatry. 2007 Apr;64(4):466-72.

PMID:
17404123
2.

Pediatric prescribing practices and the FDA Black-box warning on antidepressants.

Cheung A, Sacks D, Dewa CS, Pong J, Levitt A.

J Dev Behav Pediatr. 2008 Jun;29(3):213-5. doi: 10.1097/DBP.0b013e31817bd7c9.

PMID:
18550990
3.

Effects of Food and Drug Administration warnings on antidepressant use in a national sample.

Olfson M, Marcus SC, Druss BG.

Arch Gen Psychiatry. 2008 Jan;65(1):94-101. doi: 10.1001/archgenpsychiatry.2007.5.

PMID:
18180433
4.

Antidepressants use in pediatric populations.

Gören JL.

Expert Opin Drug Saf. 2008 May;7(3):223-5. doi: 10.1517/14740338.7.3.223 .

PMID:
18462180
5.

Persisting decline in depression treatment after FDA warnings.

Libby AM, Orton HD, Valuck RJ.

Arch Gen Psychiatry. 2009 Jun;66(6):633-9. doi: 10.1001/archgenpsychiatry.2009.46.

PMID:
19487628
7.

Relationship between antidepressant medication treatment and suicide in adolescents.

Olfson M, Shaffer D, Marcus SC, Greenberg T.

Arch Gen Psychiatry. 2003 Oct;60(10):978-82.

PMID:
14557142
8.

Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.

Pamer CA, Hammad TA, Wu YT, Kaplan S, Rochester G, Governale L, Mosholder AD.

Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):158-74. doi: 10.1002/pds.1886.

PMID:
20049836
9.

The relationship between antidepressant medication use and rate of suicide.

Gibbons RD, Hur K, Bhaumik DK, Mann JJ.

Arch Gen Psychiatry. 2005 Feb;62(2):165-72.

PMID:
15699293
10.

Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.

Rushton JL, Clark SJ, Freed GL.

Pediatrics. 2000 Jun;105(6):E82.

PMID:
10835095
11.

Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.

Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ.

Am J Psychiatry. 2007 Aug;164(8):1198-205.

PMID:
17671282
12.
13.

Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.

Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J.

CMAJ. 2008 Apr 8;178(8):1005-11. doi: 10.1503/cmaj.071265. Erratum in: CMAJ. 2008 May 20;178(11):1466.

14.

The effect of antidepressant warnings on prescribing trends in Ontario, Canada.

Kurdyak PA, Juurlink DN, Mamdani MM.

Am J Public Health. 2007 Apr;97(4):750-4. Epub 2007 Feb 28.

15.

Sociological influences on antidepressant prescribing.

Sleath B, Shih YC.

Soc Sci Med. 2003 Mar;56(6):1335-44.

PMID:
12600369
16.
17.

Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000.

Guaiana G, Andretta M, Corbari L, Mirandola M, Sorio A, D'Avanzo B, Barbui C.

J Clin Psychiatry. 2005 Jun;66(6):750-5.

PMID:
15960569
18.

Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).

Volkers AC, Heerdink ER, van Dijk L.

Pharmacoepidemiol Drug Saf. 2007 Sep;16(9):1054-62.

PMID:
17551992
19.

Antidepressants and suicidality: the basis of controversies.

Marcinko D.

Psychiatr Danub. 2007 Sep;19(3):238-40.

PMID:
17914327
20.

Supplemental Content

Support Center